ID TMOi001-A-1 AC CVCL_UL03 SY hiPSC-CD34-GFP-3G6; Clone 3G6; Reporter line 3G6; 3G6; CCRIi001-A-1 DR BioSamples; SAMEA104619935 DR hPSCreg; TMOi001-A-1 DR Wikidata; Q98133482 RX PubMed=30009677; CC From: St. Anna Kinderkrebsforschung GmbH; Vienna; Austria. CC Characteristics: CRISPR/Cas9-mediated knock-in of a IRES-GFP-NLS-PuroR construct at the 3'UTR of CD34 (PubMed=30009677). CC Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP). CC Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR). CC Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_RM92 ! CBiPSC6.2 SX Female AG <1D CA Induced pluripotent stem cell DT Created: 25-02-19; Last updated: 14-08-25; Version: 11 // RX PubMed=30009677; DOI=10.1089/scd.2018.0093; RA Husa, Anna-Maria RA Strobl, Maria Regina RA Strajeriu, Agata RA Wieser, Matthias RA Strehl, Sabine RA Fortschegger, Klaus RT "Generation of CD34 fluorescent reporter human induced pluripotent RT stem cells for monitoring hematopoietic differentiation."; RL Stem Cells Dev. 27:1376-1384(2018). //